Linked Life Data

21222483

Source:http://linkedlifedata.com/resource/pubmed/id/21222483

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21222483rdf:typepubmed:Citationlld:pubmed
pubmed-article:21222483lifeskim:mentionsumls-concept:C0020930lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C0598129lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:21222483lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:21222483pubmed:issue5lld:pubmed
pubmed-article:21222483pubmed:dateCreated2011-4-14lld:pubmed
pubmed-article:21222483pubmed:abstractTextNew enantiopure imines (1-9) with a chiral substrate to control the stereochemistry of a newly created stereogenic center have been synthesized by reaction of the commercially available (1R)-(-)-myrtenal and different primary amines. The diastereomerically enriched lithium-scorpionate compounds [Li(?(3)-mobpza)(THF)] (10) (mobpza = N-p-methylphenyl-(1R and 1S)-1-[(1R)-6,6-dimethylbicyclo[3.1.1]-2-hepten-2-yl]-2,2-bis(3,5-dimethylpyrazol-1-yl)ethylamide), [Li(?(3)-mobpza)(THF)] (11) (mobpza = N-p-methoxyphenyl-(1R and 1S)-1-[(1R)-6,6-dimethylbicyclo[3.1.1]-2-hepten-2-yl]-2,2-bis(3,5-dimethylpyrazol-1-yl)ethylamide), [Li(?(3)-fbpza)(THF)] (12) (fbpza = N-p-fluorophenyl-(1R and 1S)-1-[(1R)-6,6-dimethylbicyclo[3.1.1]-2-hepten-2-yl]-2,2-bis(3,5-dimethylpyrazol-1-yl)ethylamide), and [Li(?(3)-clbpza)(THF)] (13) (clbpza = N-p-chlorophenyl-(1R and 1S)-1-[(1R)-6,6-dimethylbicyclo[3.1.1]-2-hepten-2-yl]-2,2-bis(3,5-dimethylpyrazol-1-yl)ethylamide) were obtained by a diastereoselective 1,2-addition of an organolithium reagent to imines in good yield and with good diastereomeric excess (ca. 80%). The complexes [LiCl(?(2)-R,R-fbpzaH)(THF)] (14) and [LiCl(?(2)-R,R-clbpzaH)(THF)] (15) were obtained in enantiomerically pure form by the treatment of THF solutions of 12 or 13 with NH(4)Cl. The enantiomerically pure amines (R,R-mbpzaH) (16), (R,R-mobpzaH) (17), (R,R-fbpzaH) (18), and (R,R-clbpzaH) (19) were obtained by hydrolysis of the lithium-scorpionate compounds 10-13 with H(2)O. The lithium compound 12 was reacted with [TiCl(4)(THF)(2)] or [ZrCl(4)] to give the enantiopure complexes [MCl(3)(?(3)-R,R-fbpza)] [M = Ti (20), Zr (21)]. The amine compound 18 reacted with [MX(4)] (M = Ti, X = O(i)Pr, OEt; M = Zr; X = NMe(2)) to give the complexes [MX(3)(?(3)-R,R-fbpza)] (22-24). The reaction of Me(3)SiCl with [Zr(NMe(2))(3)(?(3)-R,R-fbpza)] (24) in different molar ratios led to the halide-amide-containing complexes [ZrCl(NMe(2))(2)(?(3)-R,R-fbpza)] (25) and [ZrCl(2)(NMe(2))(?(3)-R,R-fbpza)] (26) and the halide complex 21. The isolation of only one of the three possible diastereoisomers of complexes 25 and 26 revealed that chiral induction from the ligand to the zirconium center took place. The structures of these compounds were elucidated by (1)H and (13)C{(1)H} NMR spectroscopy, and the X-ray crystal structures of 5, 12, 14, 15, and 24 were also established.lld:pubmed
pubmed-article:21222483pubmed:languageenglld:pubmed
pubmed-article:21222483pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21222483pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:21222483pubmed:monthMarlld:pubmed
pubmed-article:21222483pubmed:issn1520-510Xlld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:López-SoleraI...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:FrancoSoniaSlld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:RodríguezAna...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:OteroAntonioAlld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:Fernández-Bae...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:TejedaJuanJlld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:Lara-SánchezA...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:Martínez-Ferr...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:Sánchez-Barba...lld:pubmed
pubmed-article:21222483pubmed:authorpubmed-author:CarriónMaría...lld:pubmed
pubmed-article:21222483pubmed:copyrightInfo© 2011 American Chemical Societylld:pubmed
pubmed-article:21222483pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21222483pubmed:day7lld:pubmed
pubmed-article:21222483pubmed:volume50lld:pubmed
pubmed-article:21222483pubmed:ownerNLMlld:pubmed
pubmed-article:21222483pubmed:authorsCompleteYlld:pubmed
pubmed-article:21222483pubmed:pagination1826-39lld:pubmed
pubmed-article:21222483pubmed:year2011lld:pubmed
pubmed-article:21222483pubmed:articleTitleDirect synthesis of NNN-donor enantiopure scorpionate ligands by an efficient diastereoselective nucleophilic addition to imines.lld:pubmed
pubmed-article:21222483pubmed:affiliationDepartamento de Qui?mica Inorga?nica, Orga?nica y Bioqui?mica, Universidad de Castilla-La Mancha, Campus Universitario, 13071-Ciudad Real, Spain. antonio.otero@uclm.eslld:pubmed
pubmed-article:21222483pubmed:publicationTypeJournal Articlelld:pubmed